Aakansha Nangarlia

机构：IQVIA (United States) · ORCID：0000-0003-2796-9092

发表论文 12 篇 · 总被引 94 次 · h-index 4

代表论文

• Mechanism of Multivalent Nanoparticle Encounter with HIV-1 for Potency Enhancement of Peptide Triazole Virus Inactivation (2014 · Journal of Biological Chemistry · 被引 58)
• Pharmacokinetic stability of macrocyclic peptide triazole HIV‐1 inactivators alone and in liposomes (2019 · Journal of Peptide Science · 被引 14)
• Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein (2023 · Biochemistry · 被引 12)
• HIV-1 Env-Dependent Cell Killing by Bifunctional Small-Molecule/Peptide Conjugates (2021 · ACS Chemical Biology · 被引 7)
• Identification of a glycan cluster in gp120 essential for irreversible HIV-1 lytic inactivation by a lectin-based recombinantly engineered protein conjugate (2020 · Biochemical Journal · 被引 3)
• Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19 (2024 · Infectious Diseases and Therapy)